VEGF-D

VEGF-D 분자 정보

영어 이름Vascular endothelial growth factor D시판 약물 수0
임상 약물 수2표적 별명C-Fos Induced Growth Factor (Vascular Endothelial Growth Factor D),FIGF,c-Fos-induced growth factor,VEGFD,VEGF-D,Vascular Endothelial Growth Factor D
최고 연구 개발 단계Phase 2 Clinical
영어 이름Vascular endothelial growth factor D
표적 별명C-Fos Induced Growth Factor (Vascular Endothelial Growth Factor D),FIGF,c-Fos-induced growth factor,VEGFD,VEGF-D,Vascular Endothelial Growth Factor D
시판 약물 수0
임상 약물 수2
최고 연구 개발 단계Phase 2 Clinical

VEGF-D 제품 목록

  • 속성

    Protein (5)

  • 제품 라이브러리

    온라인 (5)

  • Human (2)Cynomolgus (1)Mouse (2)

  • 태그

    His Tag (2)His Tag & Avi Tag (2)Fc Tag (1)

  • 마커

    Unconjugated (3)Biotin-labeled (2)

VEGF-D분자 배경

Vascular endothelial growth factor D (VEGF-D) is also known as C-fos induced growth factor (FIGF), which belongs to the PDGF / VEGF growth factor family and is active in angiogenesis, lymphangiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. This secreted protein VEGF-D / FIGF undergoes a complex proteolytic maturation, generating multiple processed forms that bind and activate VEGFR-2 and VEGFR-3. The structure and function of this protein is similar to those of VEGFC. FIGF / VEGF-D is highly expressed in lung, heart, small intestine and fetal lung. FIGF / VEGF-D may function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR / FLK1) and VEGFR-3 (FLT4) receptors.

VEGF-D분자 별명

FIGF,VEGFD

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
EG-016EG-016; Ad-VEGF-APhase 2 ClinicalArk Therapeutics LtdPeripheral Vascular Diseases
상세
EG-011EG-011; Ad-VEGF-DPhase 2 ClinicalArk Therapeutics LtdAngina Pectoris
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호